Johnson & Johnson
JNJ.N
LATEST TRADE
171.79USD
CHANGE
1.81(+1.06%)
VOLUME
1,337,715
TODAY'S RANGE
170.38 - 172.17
52 WEEK RANGE
134.83 - 173.62
As of 1:00 PM PDT Jul 23 on the New York Stock Exchange ∙ Minimum 15 minute delay
Previous Close169.98
Open171.00
Volume1,337,715
3M AVG Volume140.87
Today's High172.17
Today's Low170.38
52 Week High173.62
52 Week Low134.83
Shares Out (MIL)2,633.40
Market Cap (MIL)447,624.70
Forward P/E17.69
Dividend (Yield %)2.49
Chart not available
Token expired
Loading new token...
OK
Advanced Charting
Next Event
Dividend For JNJ.N - 1.0600 USDAug 23, 2021
Latest Developments
More
13 hours ago
U.S. CDC Says Delivered 393,929,955 Doses Of Covid-19 Vaccine As Of July 23
2 days ago
U.S. CDC Says Delivered 391,998,625 Doses Of Covid-19 Vaccine As Of July 22
2 days ago
EMA Says GBS To Be Listed As Very Rare Side Effect Of COVID-19 Vaccine Janssen
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
INDUSTRY
Biotechnology & Drugs
CONTACT INFO
1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ
08933-0001
United States
+1.732.5242455
https://www.jnj.com/
EXECUTIVE LEADERSHIP
Alex Gorsky
Chairman of the Board, Chief Executive Officer
Paulus A. Stoffels
Vice Chairman- Executive Committee, Chief Scientific Officer
Joaquin Boix Duato
Vice Chairman - Executive Committee
Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Peter M. Fasolo
Chief Human Resource Officer, Executive Vice President
Key Stats
1.95 mean rating - 21 analysts
SELLHOLDBUY
REVENUE (MM, USD)
2018
81.6K
2019
82.1K
2020
82.6K
2021(E)
93.7K
EPS (USD)
2018
8.180
2019
8.680
2020
8.030
2021(E)
9.637
Price To Earnings (TTM)25.56
Price To Sales (TTM)5.02
Price To Book (MRQ)--
Price To Cash Flow (TTM)26.11
Total Debt To Equity (MRQ)--
LT Debt To Equity (MRQ)--
Return On Investment (TTM)--
Return On Equity (TTM)--
Latest News
J&J shot recipients may need a booster; new advice on infected kids
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.
14 hours ago
U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports
Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh the risks, a U.S. Centers for Disease Control and Prevention advisory panel said on Thursday.
2 days ago
REFILE-J&J vaccine benefits outweigh its risks despite reports of neurological disorder - CDC advisory panel
Even after reports of a neurological disorder in the six weeks after inoculation with Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh risks, according to an advisory panel of the U.S. Centers for Disease Control and Prevention on Thursday.
2 days ago
EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine
Europe's medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's COVID-19 vaccine after it reviewed 108 cases reported worldwide.
2 days ago
Africa to start receiving 400 mln J&J COVID-19 vaccine doses next week
Africa will start to receive the first batch of 400 million doses of COVID-19 vaccines from Johnson & Johnson next week, the African Union's special envoy on COVID said on Thursday.
2 days ago
U.S. state officials urge support for landmark $26 billion opioid settlement
A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments.
3 days ago
Factbox: Companies pay billions of dollars over role in U.S. opioid crisis
State attorneys general on Wednesday unveiled a $26 billion settlement with the three largest U.S. drug distributors and Johnson & Johnson to resolve thousands of lawsuits by states and local governments over the companies' role in the country's opioid painkiller crisis.
3 days ago
Drug distributors, J&J reach landmark $26 bln opioid settlement
A group of state attorneys general unveiled on Wednesday a landmark, $26 billion settlement resolving claims that the three largest U.S. drug distributors and drugmaker Johnson & Johnson helped fuel a deadly nationwide opioid epidemic.
3 days ago
J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target
Johnson & Johnson on Wednesday forecast $2.5 billion in 2021 sales for its COVID-19 shot and set a lower production target for the vaccine as lengthy manufacturing problems took a toll.
3 days ago
Norway, Lithuania swap J&J, Pfizer vaccines to speed up inoculation
Norway on Wednesday signed a deal to swap 100,000 doses of its unused shots made by Johnson & Johnson with Lithuania in return for an equal number of doses from Pfizer in a move to speed up inoculations.
3 days ago
Drugmakers, pharmacies next targets for U.S. opioid settlements
With a $26 billion nationwide settlement in sight over claims that the three largest U.S. drug distributors and Johnson & Johnson helped fuel a nationwide opioid epidemic, state and local governments will soon turn their attention to pharmacies and a handful of drugmakers.
3 days ago
Johnson & Johnson forecasts $2.5 bln in 2021 sales of COVID-19 shot
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns. (Reporting by Manas Mishra in Bengaluru...
3 days ago
U.S. states to unveil $26 billion opioid settlement with drug distributors, J&J - sources
U.S. state attorneys general are expected this week to unveil a $26 billion settlement resolving claims that three major drug distributors and drugmaker Johnson & Johnson helped fuel a nationwide opioid epidemic, people familiar with the matter said on Monday.
4 days ago
Drug distributors, J&J to announce $26 bln opioid settlement this week - source
U.S. state attorneys general and lawyers for local governments are expected on Wednesday to unveil a landmark, $26 billion settlement resolving claims that the three largest U.S. drug distributors and drugmaker Johnson & Johnson helped fuel a nationwide opioid epidemic,...
5 days ago
J&J exploring putting talc liabilities into bankruptcy-sources
Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection, according to seven people familiar with the matter.
5 days ago
Yemen to get more COVID-19 vaccines by end of month - health ministry
Yemen expects to get a second batch of COVID-19 shots by the end of this month through the COVAX global vaccine-sharing scheme, the health ministry said on Sunday.
6 days ago
FDA investigating how a known carcinogen wound up in J&J sunscreen
The U.S. Food and Drug Administration (FDA) is investigating how a cancer-causing chemical ended up in Johnson & Johnson sunscreens, after the company said it had done internal testing and found low levels of benzene in some, the regulator said on Friday.
8 days ago
FDA investigating carcinogen found in recalled J&J sunscreen products
The U.S. Food and Drug Administration said on Friday it is investigating the root cause of a cancer-causing chemical found in some of Johnson & Johnson's recalled sunscreen products.
8 days ago
Target removes J&J sunscreens from stores, website
Target Corp said on Friday it has removed Johnson & Johnson's Neutrogena aerosol sunscreen products from its stores and website after the pharmaceutical company said it had detected a cancer-causing chemical in some samples.
8 days ago
Pharmacies pull J&J sunscreens off shelves after carcinogen found in some sprays
Pharmacy chains CVS Health, Walgreens Boots Alliance and retailer Walmart Inc began pulling Johnson & Johnson's sunscreen products off their shelves after J&J said it had detected a cancer-causing chemical in some samples.
9 days ago
U.S. begins shipping 3.2 million COVID shots to the Philippines - White House
The United States has started shipping 3.2 million doses of Johnson & Johnson's COVID-19 vaccine to the Philippines, the White House said on Thursday, as Washington continues its coronavirus diplomacy by sharing doses with developing nations.
9 days ago
Vietnam approves Johnson & Johnson's COVID-19 vaccine as daily cases hit record
Vietnam on Thursday approved Johnson & Johnson's Janssen COVID-19 vaccine on Thursday for emergency use, as the country tries to boost supplies at a time of record numbers of new infections.
9 days ago
Vietnam approves Johnson & Johnson's COVID-19 vaccine
Vietnam has approved the Janssen COVID-19 vaccine of Johnson & Johnson's for emergency use, the sixth brand to be endorsed in the Southeast Asian country, as it seeks to expedite its inoculations programme amid its worst outbreak so far.
9 days ago
J&J lobbyist joins Akin Gump as healthcare dollars flow
A top lobbyist for drugmaker Johnson & Johnson and former senior policy aide to New Jersey Senator Robert Menendez is joining the public law and policy practice at Akin Gump Strauss Hauer & Feld, the firm said Tuesday.
11 days ago
Moldova gets 500,000 doses of J&J's COVID-19 vaccine from U.S. - State Dept
The United States has sent 500,000 doses of Johnson & Johnson's COVID-19 vaccine to Moldova as part of Washington's coronavirus diplomacy to send surplus shots overseas to help fight the global pandemic, the U.S. Department of State said on Tuesday.
11 days ago
EU reviews J&J COVID-19 shot for rare nerve disorder after U.S. warning
The European Medicines Agency (EMA) said on Tuesday it was analysing data on rare cases of a nerve disorder reported among recipients of Johnson & Johnson's COVID-19 vaccine, after the United States added a warning label to the shot.
11 days ago
UPDATE 1-J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports - WSJ
Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their COVID-19 vaccines could eliminate or reduce the risk of rare blood clots linked to the shots, the Wall Street Journal reported, citing people close to the process.
11 days ago
BRIEF-J&J, Astrazeneca Explore COVID-19 Vaccine Modification In Response To Blood Clots - WSJ
* J&J, ASTRAZENECA EXPLORE COVID-19 VACCINE MODIFICATION IN RESPONSE TO RARE BLOOD CLOTS - WSJ
11 days ago
J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports - WSJ
Johnson & Johnson and AstraZeneca are conducting early-stage research into whether potential modifications to their COVID-19 vaccines could reduce or eliminate the risk of rare but serious blood clots linked to the shots, the Wall Street Journal reported, citing people close...
11 days ago
Italy's Enel to sell green power to Johnson & Johnson in virtual deal
Europe’s biggest utility Enel has agreed to sell 270 gigawatt hours of renewable power a year to Johnson & Johnson to help the U.S. healthcare giant reach climate targets.
12 days ago
U.S. puts new warning on J&J coronavirus vaccine for autoimmune disorder
The U.S. Food and Drug Administration on Monday added a warning to the fact sheet for Johnson & Johnson's COVID-19 vaccine saying that data suggests there is an increased risk of a rare neurological disorder in the six weeks after inoculation.
12 days ago
Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effects
Johnson & Johnson said on Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.
12 days ago
Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effects
Johnson & Johnson said on Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine. (Reporting by Trisha...
12 days ago
U.S. to announce new warning on J&J coronavirus vaccine for autoimmune disorder -Washington Post
The U.S. Food and Drug Administration is expected to announce a new warning on Johnson & Johnson's coronavirus vaccine related to autoimmune disorder, the Washington Post reported on Monday, citing four people familiar with the matter. (Reporting by Lisa Lambert Editing...
12 days ago
U.S. shipping COVID-19 vaccines to Indonesia, Bhutan, Nepal
The United States is shipping 3 million doses of the Moderna COVID-19 vaccine to Indonesia, with another 1.5 million doses of the Johnson & Johnson vaccine heading to Nepal and 500,000 Moderna doses to Bhutan, a White House official said on Friday.
15 days ago
EU finds potential link between heart inflammation and mRNA COVID shots
Europe's drug regulator has found a possible link between very rare heart inflammation and COVID-19 vaccines from Pfizer-BioNTech and Moderna, it said on Friday, stressing that the benefits of the shots outweighed any risks.
15 days ago
U.S. donation of 1.4 million COVID-19 vaccine doses arrives in Afghanistan
A U.S. donation of more than 1.4 million doses of the Johnson & Johnson COVID-19 vaccine arrived in Afghanistan on Friday, the first of two shipments this month, the U.N. children's agency UNICEF said in a statement.
15 days ago
EU regulator lists heart condition as possible side effect of mRNA vaccines
Europe's drug regulator on Friday recommended adding heart inflammation as a possible side effect of mRNA COVID-19 vaccines from Pfizer and Moderna and advised people with a history of capillary leak syndrome to avoid getting Johnson & Johnson's coronavirus shot. (Reporting...
15 days ago
U.S. sending 1 million J&J vaccine doses to Bolivia, 1 million to Paraguay
The United States is sending one million Johnson & Johnson COVID-19 vaccine doses to Bolivia and one million to Paraguay, White House spokeswoman Jen Psaki said told reporters on Wednesday.
17 days ago
New Zealand health regulator approves use of Janssen COVID-19 vaccine
New Zealand said on Wednesday that its health regulator Medsafe has given provisional approval for a coronavirus vaccine developed by Janssen, the pharmaceutical unit of Johnson & Johnson.
18 days ago
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.
Apps​Newsletters​Advertise with UsAdvertising Guidelines​Cookies​Terms of UsePrivacyDo Not Sell My Personal Information
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All Rights Reserved.